A 2023 Lancet study reveals 15-20% of type 2 diabetes patients exhibit autoimmune markers, with new ADA guidelines advocating combined GADA/ICA/IAA testing to prevent diagnostic delays and improve out...
A breakthrough AI model accurately predicts lower-extremity amputation risks in diabetics using explainable machine learning, potentially reducing procedures by 85% through early interventions, per a ...
